Voloridge Investment Management, LLC Axogen, Inc. Transaction History

Voloridge Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$10.62 - $13.12 $319,895 - $395,200	-30,122 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $95,447 - $140,378	12,986 Added 75.78%	30,122 $278,000
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $143,599 - $297,138	17,136 New	17,136 $178,000
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $588,995 - $979,903	-52,683 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $331,544 - $561,074	27,423 Added 108.56%	52,683 $657,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $198,542 - $273,344	10,732 Added 73.87%	25,260 $500,000
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $277,122 - $419,474	-18,955 Reduced 56.61%	14,528 $306,000
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $300,869 - $673,391	17,605 Added 110.88%	33,483 $684,000
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $540,645 - $887,580	15,878 New	15,878 $585,000

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.